Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Generating comparative evidence on new drugs and devices after approval — Andrea Cipriani (2020) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Generating comparative evidence on new drugs and devices after approval
Shared by
John P A Ioannidis
Stanford University
Generating comparative evidence on new drugs and devices after approval
Article
2020
en
Authors
+6 more
AC
Andrea Cipriani
John P A Ioannidis
Stanford University
PR
Peter M. Rothwell
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2018
The Comparative Effectiveness of Innovative Treatments for Cancer (CEIT-Cancer) project: Rationale and design of the database and the collection of evidence available at approval of novel drugs
Aviv Ladanie
,
Benjamin Speich
,
Florian Naudet
,
Arnav Agarwal
,
Tiago Pereira
,
Francesco Sclafani
,
Juan Martín-Liberal
,
Thomas Schmid
,
Hannah Ewald
,
John P A Ioannidis
,
Heiner C. Bucher
,
Benjamin Kasenda
,
Lars G. Hemkens
Book
1992
Restenosis after Intervention with New Mechanical Devices
Patrick W. Serruys
,
Bradley H. Strauss
,
Spencer B. King
Chapter in a book
2001
Clinical Studies on New Drugs
Trevor T. Hansel
,
Peter J Barnes
Article
1992
Restenosis after coronary angioplasty: a proposal of new comparative approaches based on quantitative angiography
Patrick W. Serruys
,
David P. Foley
,
Pim J. de Feyter
Heart
Article
1988
Bleomycin‐detectable iron in serum from leukaemic patients before and after chemotherapy Therapeutic implications for treatment with oxidant‐generating drugs
Barry Halliwell
,
Okezie I. Aruoma
,
G J Mufti
,
Adrian Bomford
FEBS Letters
Discussion(0)
No comments yet. Be the first to comment.